Clinical Trial Update: Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial at Yale University is investigating the synaptotrophic effects of psilocybin for opioid use disorder and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Yale University | Conditions: Opioid Use Disorder | Phase 1 | Status: RECRUITING